Abyrx develops, manufactures and provides specialty biosurgical products, with a core focus on bone putty used in surgical procedures. The company says it will use new capital to manage demand for its bone putty products and to accelerate pipeline development activities. Abyrx expanded its exclusive worldwide license with Bezwada Biomedical to include development, manufacture and commercialization of Bezwada’s proprietary adhesive technology for soft tissue applications. That expanded agreement gives Abyrx exclusive access to proprietary materials and manufacturing it will use to develop products for surgical site hemostasis, sealing and fixation. The company was founded in 2013 and is led by President and CEO John J. Pacifico. Abyrx is based in Irvington, N.Y.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2016